Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for postoperative cognitive dysfunction after partial hepatectomy in elderly patients
ChiCTR2000034677Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Mianyang Central Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in post-operative cognitive decline (POCD) (2 arms), sponsored by Department of Anesthesiology, Mianyang Central Hospital. Primary endpoints: Operation time, Intraoperative blood loss and 10 more. Started Jul 2020; status: recruiting.
02
Drugs
remimazolam
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2000034677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034677.